Search for: "In re: Suboxone Antitrust Litigation" Results 1 - 3 of 3
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
antitrust claim against Suboxone, including false advertising, survives summary judgment
25 Aug 2022, 10:13 am by Rebecca Tushnet
In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litig., --- F.Supp.3d ----, MDL NO. 2445 13-MD-2445, CIV. [read post]
43(B)log - http://tushnet.blogspot.com/
Product Liability Hopping & the FDA’s Generic Drug Proposal – Awful Together
4 Jun 2015, 1:00 pm
  We don’t normally blog about drug-related antitrust issues, but last December the court in In re Suboxone (Buprenorphine Hydrochloride & Naloxone) Antitrust Litigation, ___ F. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
FDA/FTC Workshop on a Competitive Marketplace for Biosimilars
9 Mar 2020, 1:21 pm by Unknown
Would help litigation, clarity. $3 million to litigate a patent, which is a big expense. [read post]
43(B)log - http://tushnet.blogspot.com/